Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kent E Wallner

Showing results (71-80 of 114) with videos related to

Pageof 12
Sort By:
BJU International|August 2, 2006
Brachytherapy in men aged < or = 54 years with clinically localized prostate cancerGregory S Merrick, Kent E Wallner, Wayne M Butler, et al.
Urology|December 20, 2005
Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancerMark A Moyad, Gregory S Merrick, Wayne M Butler, et al.
Urologic Oncology|December 1, 2009
Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostateNathan Bittner, Gregory S Merrick, Renee Stewart, et al.
International Journal of Radiation Oncology, Biology, Physics|July 23, 2003
Isodose patterns in patients with inadequate prostate brachytherapy coverageDaniel R Reed, Kent E Wallner, Gregory Merrick, et al.
Cancer Journal (Sudbury, Mass.)|May 4, 2007
Long-term rectal function after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Brachytherapy|April 28, 2004
The effect of hormonal manipulation on urinary function following permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|February 10, 2007
Androgen deprivation therapy does not impact cause-specific or overall survival in high-risk prostate cancer managed with brachytherapy and supplemental external beamGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|June 14, 2011
Distant metastases following permanent interstitial brachytherapy for patients with clinically localized prostate cancerAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Journal of Contemporary Brachytherapy|January 30, 2014
Time to failure after definitive therapy for prostate cancer: implications for importance of aggressive local treatmentAl V Taira, Gregory S Merrick, Wayne M Butler, et al.
International Journal of Radiation Oncology, Biology, Physics|March 27, 2010
Permanent prostate brachytherapy in prostate glands <20 cm(3)Jyoti Mayadev, Gregory S Merrick, Joshua R Reed, et al.
Pageof 12

Showing results (71-80 of 114) with videos related to

Sort By:
Pageof 12
BJU International|August 2, 2006
Brachytherapy in men aged < or = 54 years with clinically localized prostate cancerGregory S Merrick, Kent E Wallner, Wayne M Butler, et al.
Urology|December 20, 2005
Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancerMark A Moyad, Gregory S Merrick, Wayne M Butler, et al.
Urologic Oncology|December 1, 2009
Obesity does not correlate with adverse pathologic findings on transperineal template-guided mapping biopsy of the prostateNathan Bittner, Gregory S Merrick, Renee Stewart, et al.
International Journal of Radiation Oncology, Biology, Physics|July 23, 2003
Isodose patterns in patients with inadequate prostate brachytherapy coverageDaniel R Reed, Kent E Wallner, Gregory Merrick, et al.
Cancer Journal (Sudbury, Mass.)|May 4, 2007
Long-term rectal function after permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
Brachytherapy|April 28, 2004
The effect of hormonal manipulation on urinary function following permanent prostate brachytherapyGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|February 10, 2007
Androgen deprivation therapy does not impact cause-specific or overall survival in high-risk prostate cancer managed with brachytherapy and supplemental external beamGregory S Merrick, Wayne M Butler, Kent E Wallner, et al.
International Journal of Radiation Oncology, Biology, Physics|June 14, 2011
Distant metastases following permanent interstitial brachytherapy for patients with clinically localized prostate cancerAl V Taira, Gregory S Merrick, Robert W Galbreath, et al.
Journal of Contemporary Brachytherapy|January 30, 2014
Time to failure after definitive therapy for prostate cancer: implications for importance of aggressive local treatmentAl V Taira, Gregory S Merrick, Wayne M Butler, et al.
International Journal of Radiation Oncology, Biology, Physics|March 27, 2010
Permanent prostate brachytherapy in prostate glands <20 cm(3)Jyoti Mayadev, Gregory S Merrick, Joshua R Reed, et al.
Pageof 12